Q Biomed (QBIO)
(Delayed Data from OTC)
$0.00 USD
0.00 (0.00%)
Updated Oct 17, 2024 02:28 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Q Biomed Inc. [QBIO]
Reports for Purchase
Showing records 1 - 20 ( 20 total )
Company: Q Biomed Inc.
Industry: Medical Services
Company: Q Biomed Inc.
Industry: Medical Services
Company: Q Biomed Inc.
Industry: Medical Services
Company: Q Biomed Inc.
Industry: Medical Services
Company: Q Biomed Inc.
Industry: Medical Services
Company: Q Biomed Inc.
Industry: Medical Services
3Q19 Recap - Sr89 Manufacturing Approval Appears Imminent
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Q Biomed Inc.
Industry: Medical Services
Company: Q Biomed Inc.
Industry: Medical Services
Company: Q Biomed Inc.
Industry: Medical Services
Model Update - 4Q19 Launch Likely for Metastron/Sr89
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Q Biomed Inc.
Industry: Medical Services
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Q Biomed Inc.
Industry: Medical Services
FY1Q19 Recap - Strontium-89 Launch on Track for 2H19
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Q Biomed Inc.
Industry: Medical Services
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Q Biomed Inc.
Industry: Medical Services
Company: Q Biomed Inc.
Industry: Medical Services
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Q Biomed Inc.
Industry: Medical Services
Company: Q Biomed Inc.
Industry: Unclassified
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Q Biomed Inc.
Industry: Unclassified
We launch coverage with a Buy rating and $6.75/share price target
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Q Biomed Inc.
Industry: Unclassified
Company: Q Biomed Inc.
Industry: Unclassified
Company: Q Biomed Inc.
Industry: Unclassified
We initiate coverage of Q BioMed Inc. with a price target of $3.85.
Provider: SEETHRUEQUITY, LLC
Analyst: TANDON A
|